Neoadjuvant therapy for advanced pancreatic neuroendocrine tumors: an emerging treatment modality?

Iraklis Perysinakis, Chrysanthi Aggeli, Gregory Kaltsas, George N. Zografos

Download PDF

OBJECTIVE: Complete surgical resection is the only potentially curative treatment of localized pancreatic neuroendocrine tumors. Unfortunately, a significant proportion of these patients present with unresectable locally advanced tumors or massive metastatic disease. Recently, a new therapeutic approach for this subset of patients has emerged consisting of neoadjuvant therapy followed by surgical exploration in responders …

Severe resistant hypoglycemia in a patient with a pancreatic neuroendocrine tumor on sunitinib treatment

Athanasios Fountas, Stelios Tigas, Zoe Giotaki, Dimitrios Petrakis, George Pentheroudakis, Agathocles Tsatsoulis

Download PDF

OBJECTIVE: Sunitinib is a tyrosine kinase inhibitor used in the therapy of pancreatic neuroendocrine tumors (PNETs), metastatic renal cancer and gastrointestinal stromal tumors. We describe a patient with PNET who presented with severe hypoglycemia following sunitinib administration …